Report - Update on MDS 2015 - prIME Oncology...Garcia-Manero, et al. Blood. 2016;128: Abstract 345. Phase II Study of Nivolumab or Ipilimumab With Azacitidine In Patients With MDS. Garcia-Manero

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form